Ikarian Capital, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Ikarian Capital, LLC
- $606 Million
- Q4 2024
A detailed history of Ikarian Capital, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 178,989 shares of RARE stock, worth $6.93 Million. This represents 1.24% of its overall portfolio holdings.
Number of Shares
178,989
Previous 179,000
0.01%
Holding current value
$6.93 Million
Previous $9.94 Million
24.27%
% of portfolio
1.24%
Previous 1.74%
Shares
8 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
84.3MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$388 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$217 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$166 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$105 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$97.2 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.71B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...